Leadership Group

领导小组

• 批准号: 9927572
• 负责人: Karen Kesler
• 金额: $ 313.53万
• 依托单位: RHO FEDERAL SYSTEMS DIVISION, INC.
• 依托单位国家: 美国
• 资助国家: 美国
• 起止时间: 至
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/9927572
• 关键词: Address; Allergic Disease; Area; Bioinformatics; Budgets; Clinical; Clinical Research; Collaborations; Communicable Diseases; Communication; Data; Decision Making; Disease; Funding; Goals; Group Structure; Immune System Diseases; Individual; Industry; Information Systems; Leadership; Methods; Mission; Monitor; National Institute of Allergy and Infectious Disease; Occupational activity of managing finances; Online Systems; Performance; Procedures; Process; Protocols documentation; Research Design; Resolution; Resources; Schedule; Standardization; System; Teleconferences; Time; U-Series Cooperative Agreements; United States National Institutes of Health; Work; cost; design; functional group; improved; meetings; member; operation; prevent; programs; rho; statistics; success; tool; web site

PROJECT SUMMARY/ABSTRACT—LEADERSHIP GROUP The leadership group (LG) will provide strategic and operational direction to the Center. The LG consists of a director, a senior project manager, the disease-specific group leaders, the centralized group leaders, an operations team, and various other Center committees. DAIT staff representing each of the three disease areas, bioinformatics, regulatory, and statistics (as needed) will also be considered part of the larger, external leadership group. The proposed LG steering committee provides consistency and clear communication across multiple studies and functional groups. The LG structure is designed to meet the following primary objectives: • Centralize and facilitate open lines of communication between Center group leaders and DAIT • Standardize processes and procedures across the entire program • Address high-level issues regarding study design, implementation, and analysis • Keep the Center current with industry and NIH standards • Provide administrative support to the Center • Allocate resources across the Center • Manage the financial aspects of the Center Members of the LG will build on our past success with coordinating DAIT studies to develop effective collaboration and communication channels for the Center. These same channels will be used for decision- making and issue resolution. We have found through our work with large multi-protocol NIH coordinating centers that effective communication requires a combination of approaches, including scheduled and ad hoc meetings and teleconferences, use of a collaboration portal to share documents and status information, and other tools and processes we have developed over time. Ongoing monitoring and tracking of LG functions and progress is essential to maintaining timely, high quality work across the Center. Activities must be monitored at the group level and across the Center. The LG director and senior project manager assume responsibility for monitoring work across the Center. With the goal of providing all stakeholders with the information needed to evaluate progress and identify issues and monitor resources, Rho utilizes a number of standard processes, tools, and activities that can be tailored to the needs of individual projects. As new needs arise, Rho refines these items to continuously improve our tracking and monitoring methods.

项目概要/摘要-领导小组 领导小组将为中心提供战略和业务指导。LG由 由一名主任、一名高级项目经理、特定疾病小组组长、中央小组组长、 运营团队和其他各种中心委员会。DAIT工作人员代表三种疾病中的每一种 生物信息学、监管和统计（根据需要）也将被视为更大的外部 领导小组。 拟议的LG指导委员会在多个部门之间提供一致性和明确的沟通， 研究和功能组。LG结构旨在实现以下主要目标： ·集中和促进中心组领导和DAIT之间的开放式沟通渠道 ·标准化整个项目的流程和程序 ·解决有关研究设计，实施和分析的高层次问题 ·保持中心与行业和NIH标准同步 ·为中心提供行政支持 ·在整个中心分配资源 ·管理中心的财务方面 LG成员将在我们过去成功的基础上，协调DAIT研究， 沟通和交流渠道。这些渠道将用于决策- 制定和解决问题。通过与大型多协议NIH协调工作， 中心，有效的沟通需要结合的方法，包括预定和特设 会议和电话会议，使用协作门户共享文件和状态信息，以及 其他工具和流程，我们已经开发了一段时间。 持续监控和跟踪LG的功能和进展对于保持及时、高质量的 在整个中心的质量工作。活动必须在小组一级和整个中心进行监测。的LG 主任和高级项目经理负责监督整个中心的工作。 目标是向所有利益攸关方提供评估进展和确定 问题和监控资源时，Rho使用了许多标准流程、工具和活动， 根据个别项目的需要量身定制。随着新需求的出现，Rho不断完善这些项目， 改进我们的跟踪和监测方法。